Medicine

What to know about the powerful new cholesterol pill

FDA approves new pill to slash cholesterol levels

Lipfendra can lower cholesterol levels far below what can be achieved with statins.

US appeals court revives hundreds of private lawsuits linking Tylenol to autism

NUS names professorship after liver pathology pioneer Aileen Wee

Pathologist Aileen Wee hopes the professorship will benefit scholars who are actively pursuing research “to uncover some of the many unknowns in the diseased liver for the betterment of patients”.

India med school hopefuls beset with anxiety before they retake scandal-tainted exam

Alima Javed, 20, said she will sit the upcoming National Eligibility cum Entrance Test re-test.

India limits cough syrup sales to pharmacies after contamination cases

Since 2022, India-made cough syrups have been linked to the deaths of more than 140 children in Africa and Central Asia.

China lures foreign patients with cutting-edge, cheap medical care

A fellow New Zealand patient who had received the treatment in China introduced Stuart Lye to a hospital in Shanghai.

Lung cancer patients on drug from China’s Akeso lived longer

The new study by Chinese firm Akeso targeted squamous non-small cell lung cancer, a condition often linked with smoking.

Experimental pancreatic cancer pill doubles survival chances, boosts quality of life

Revolution Medicine’s daraxonrasib drug reduced the time from diagnosis of pancreatic cancer to a patient’s death to 13.2 months versus 6.7 months for those on standard chemotherapy.

Malaysia govt will ensure critical medicine and medical device stocks remain sufficient: Minister

A total of 72 per cent of medical items are widely available and 81 per cent of medical devices are available, said a minister.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.